[go: up one dir, main page]

ZA200005797B - Imidazo pyridine derivatives which inhibit gastric acid secretion. - Google Patents

Imidazo pyridine derivatives which inhibit gastric acid secretion. Download PDF

Info

Publication number
ZA200005797B
ZA200005797B ZA200005797A ZA200005797A ZA200005797B ZA 200005797 B ZA200005797 B ZA 200005797B ZA 200005797 A ZA200005797 A ZA 200005797A ZA 200005797 A ZA200005797 A ZA 200005797A ZA 200005797 B ZA200005797 B ZA 200005797B
Authority
ZA
South Africa
Prior art keywords
compound
formula
carboxamide
pyridine
dimethyl
Prior art date
Application number
ZA200005797A
Other languages
English (en)
Inventor
Kosrat Amin
Michael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200005797B publication Critical patent/ZA200005797B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200005797A 1998-04-29 2000-10-18 Imidazo pyridine derivatives which inhibit gastric acid secretion. ZA200005797B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds

Publications (1)

Publication Number Publication Date
ZA200005797B true ZA200005797B (en) 2002-01-18

Family

ID=20411154

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200005797A ZA200005797B (en) 1998-04-29 2000-10-18 Imidazo pyridine derivatives which inhibit gastric acid secretion.
ZA200005796A ZA200005796B (en) 1998-04-29 2000-10-18 Imidazo pyridine derivatives which inhibit gastric acid secretion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200005796A ZA200005796B (en) 1998-04-29 2000-10-18 Imidazo pyridine derivatives which inhibit gastric acid secretion.

Country Status (34)

Country Link
US (2) US6313136B1 (ja)
EP (4) EP1073656B1 (ja)
JP (2) JP3883383B2 (ja)
KR (3) KR100595806B1 (ja)
CN (2) CN1165535C (ja)
AR (2) AR015769A1 (ja)
AT (4) ATE312101T1 (ja)
AU (2) AU769108B2 (ja)
BR (2) BR9909996B1 (ja)
CA (2) CA2329921A1 (ja)
CZ (2) CZ293977B6 (ja)
DE (4) DE69937076T2 (ja)
DK (2) DK1073657T3 (ja)
EE (2) EE04676B1 (ja)
ES (2) ES2252975T3 (ja)
HK (5) HK1033457A1 (ja)
HU (2) HUP0102313A3 (ja)
ID (2) ID26819A (ja)
IL (4) IL139297A0 (ja)
IS (2) IS5683A (ja)
MY (2) MY121379A (ja)
NO (2) NO317262B1 (ja)
NZ (2) NZ507639A (ja)
PL (2) PL343797A1 (ja)
RU (2) RU2238271C2 (ja)
SA (2) SA99200064B1 (ja)
SE (1) SE9801526D0 (ja)
SI (1) SI1073656T1 (ja)
SK (2) SK285768B6 (ja)
TR (4) TR200003149T2 (ja)
TW (2) TW490466B (ja)
UA (2) UA67769C2 (ja)
WO (2) WO1999055705A1 (ja)
ZA (2) ZA200005797B (ja)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
JP2004518709A (ja) * 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 新規放出修飾製剤
US20040082605A1 (en) * 2001-03-08 2004-04-29 Arne Eek Use
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
TWI351405B (en) 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
BR0316201A (pt) 2002-11-19 2005-10-04 Altana Pharma Ag Imidazopiridinas 8-substituìdas
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
DK2476667T3 (da) * 2003-02-26 2014-09-15 Sugen Inc Aminoheteroaryl-forbindelser som proteinkinase-inhibitorer
WO2004080967A1 (en) 2003-03-10 2004-09-23 Altana Pharma Ag Novel process for the preparation of roflumilast
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
EP1711498A2 (en) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE602005009257D1 (de) * 2004-12-17 2008-10-02 Pfizer Chroman-derivate als säurepumpenantagonisten
JP5383183B2 (ja) 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
EP1863811B1 (en) * 2005-03-21 2014-03-12 MEI Pharma, Inc. Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
AR055321A1 (es) * 2005-03-24 2007-08-15 Glaxo Group Ltd Compuestos de imidazopiridina uso para a fabricacion de un medicamento para el tratamiento o profilaxis de enfermedades o trastornos en los que se requiere un antagonista de una bomba de acido y composicion farmaceutica que lo comprende
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
WO2007066185A2 (en) 2005-12-05 2007-06-14 Pfizer Products Inc. Polymorphs of a c-met/hgfr inhibitor
DE602006018354D1 (de) 2005-12-05 2010-12-30 Pfizer Prod Inc Verfahren zur behandlung von abnormalem zellwachstum
CA2645007A1 (en) * 2006-03-17 2007-09-27 Raqualia Pharma Inc. Chromane derivatives
US8728527B2 (en) 2006-07-24 2014-05-20 Luminus Biosciences, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
EP1974729A1 (en) * 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
WO2009122435A2 (en) * 2008-03-31 2009-10-08 Council Of Scientific & Industrial Research A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
BRPI1013288A2 (pt) 2009-07-09 2016-03-29 Raqualia Pharma Inc uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
KR102314290B1 (ko) * 2013-06-25 2021-10-21 에프. 호프만-라 로슈 아게 척수성 근위축증을 치료하기 위한 화합물
EP3083619B1 (en) 2013-12-16 2021-11-03 Asana BioSciences, LLC P2x3 and/or p2x2/3 compounds and methods
ES2692243T3 (es) * 2014-03-24 2018-11-30 Arqule, Inc. Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3H-imidazo[4,5-b]piridin-2-il)piridin-2-amina
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
US11666888B2 (en) 2018-02-05 2023-06-06 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
BR112020019277B1 (pt) * 2018-04-10 2024-01-16 Bayer Aktiengesellschaft Processo para produção de ácidos 2,6-dialquilfenil acéticos, e seus intermediários
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
BR112022008384A2 (pt) 2019-11-04 2022-07-12 Cinclus Pharma Holding AB Formulação oral de x842
MX2024005292A (es) 2021-11-05 2024-05-17 Cinclus Pharma Holding Ab Publ Polimorfos de la sal de clorhidrato de glurato de linaprazan.
WO2023079093A1 (en) 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the mesylate salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
WO2024149833A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the maleic acid salt of linaprazan glurate
WO2024149834A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrobromide salt of linaprazan glurate
WO2024161317A1 (ko) * 2023-02-01 2024-08-08 제일약품주식회사 약학적 제제, 이의 제조 방법, 및 정제용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
TWI250159B (en) 2006-03-01
EE04676B1 (et) 2006-08-15
HUP0102425A2 (hu) 2001-11-28
BR9909995B1 (pt) 2010-07-13
JP3692034B2 (ja) 2005-09-07
HUP0102313A3 (en) 2002-10-28
CZ20003981A3 (cs) 2001-03-14
DK1073656T3 (da) 2006-01-16
JP2002513024A (ja) 2002-05-08
DE69937077D1 (de) 2007-10-18
EP1491542B1 (en) 2007-09-05
SA99200064B1 (ar) 2006-10-11
EP1491543A1 (en) 2004-12-29
KR20010043133A (ko) 2001-05-25
EE04916B1 (et) 2007-10-15
EP1073657A1 (en) 2001-02-07
IL139297A0 (en) 2001-11-25
AR015768A1 (es) 2001-05-16
EP1073656B1 (en) 2005-10-19
CZ293977B6 (cs) 2004-09-15
AU4300799A (en) 1999-11-16
ZA200005796B (en) 2002-01-18
IS5683A (is) 2000-10-25
NO20005450D0 (no) 2000-10-27
DE69927803T2 (de) 2006-07-06
KR100595805B1 (ko) 2006-07-03
TR200003149T2 (tr) 2001-03-21
EP1073657B1 (en) 2005-12-07
RU2235725C2 (ru) 2004-09-10
ES2252975T3 (es) 2006-05-16
AR015769A1 (es) 2001-05-16
HK1033317A1 (en) 2001-08-24
ID27530A (id) 2001-04-12
AU769108B2 (en) 2004-01-15
AU769190B2 (en) 2004-01-22
NO317262B1 (no) 2004-09-27
ATE307130T1 (de) 2005-11-15
PL195000B1 (pl) 2007-07-31
EP1491542A2 (en) 2004-12-29
NO20005451L (no) 2000-12-27
WO1999055705A1 (en) 1999-11-04
PL343797A1 (en) 2001-09-10
MY121379A (en) 2006-01-28
SK14922000A3 (sk) 2001-06-11
DE69937076T2 (de) 2008-05-29
DE69937077T2 (de) 2008-05-29
CZ292567B6 (cs) 2003-10-15
CZ20003982A3 (cs) 2001-02-14
US6313137B1 (en) 2001-11-06
US6313136B1 (en) 2001-11-06
CN1165535C (zh) 2004-09-08
IS5684A (is) 2000-10-25
WO1999055706A9 (en) 2000-03-16
SK285768B6 (sk) 2007-07-06
PL343801A1 (en) 2001-09-10
EE200000664A (et) 2002-04-15
DE69928792D1 (de) 2006-01-12
DE69937076D1 (de) 2007-10-18
CA2329922C (en) 2006-04-11
NZ507638A (en) 2003-10-31
IL139297A (en) 2007-06-03
IL139200A0 (en) 2001-11-25
BR9909995A (pt) 2000-12-26
RU2238271C2 (ru) 2004-10-20
TW490466B (en) 2002-06-11
KR20050121760A (ko) 2005-12-27
TR200003176T2 (tr) 2001-03-21
HK1071139A1 (en) 2005-07-08
CN1306533A (zh) 2001-08-01
CN1307577A (zh) 2001-08-08
UA67769C2 (uk) 2004-07-15
HK1033457A1 (en) 2001-08-31
CA2329922A1 (en) 1999-11-04
BR9909996A (pt) 2000-12-26
NO20005451D0 (no) 2000-10-27
SK14912000A3 (sk) 2001-06-11
SE9801526D0 (sv) 1998-04-29
JP3883383B2 (ja) 2007-02-21
EP1073656A1 (en) 2001-02-07
MY121389A (en) 2006-01-28
KR100595806B1 (ko) 2006-07-03
ATE372339T1 (de) 2007-09-15
KR100650472B1 (ko) 2006-11-28
HUP0102313A2 (hu) 2001-12-28
HK1036981A1 (en) 2002-01-25
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
DE69927803D1 (de) 2006-03-02
UA66846C2 (uk) 2004-06-15
TR200102612T2 (tr) 2002-06-21
HUP0102425A3 (en) 2002-12-28
DK1073657T3 (da) 2006-03-13
EE200000626A (et) 2002-04-15
HK1036984A1 (en) 2002-01-25
IL139200A (en) 2010-04-29
CA2329921A1 (en) 1999-11-04
BR9909996B1 (pt) 2010-08-24
ID26819A (id) 2001-02-15
NZ507639A (en) 2004-01-30
SA99200065B1 (ar) 2006-11-07
DE69928792T2 (de) 2006-07-20
NO318203B1 (no) 2005-02-14
JP2002513025A (ja) 2002-05-08
EP1491542A3 (en) 2005-01-05
ATE312101T1 (de) 2005-12-15
ES2249913T3 (es) 2006-04-01
TR200102728T2 (tr) 2002-06-21
EP1491543B1 (en) 2007-09-05
KR20010043134A (ko) 2001-05-25
ATE372340T1 (de) 2007-09-15
SA99200065A (ar) 2005-12-03
AU4300699A (en) 1999-11-16
CN1174980C (zh) 2004-11-10
NO20005450L (no) 2000-12-22

Similar Documents

Publication Publication Date Title
ZA200005797B (en) Imidazo pyridine derivatives which inhibit gastric acid secretion.
AU752187B2 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
US6613775B1 (en) Imidazo[1,2-a]pyridine compounds
US20040220209A1 (en) Novel imidazopyridine compounds with therapeutic effect
AU2002324402A1 (en) Novel imidazopyridine compounds with therapeutic effect